Latest Pharmacological Technology Briefings Now Available
Our latest batch on pharmacological technologies in development is now available.
- Anacetrapib in combination with a statin for patients with primary hypercholesterolaemia or mixed dyslipidaemia – adjunctive therapy
- Nivolumab for small cell lung cancer in combination with ipilimumab – first line maintenance therapy
- Liraglutide (Victoza) to reduce the risk of cardiovascular events in patients with type 2 diabetes mellitus
- Cinryze (C1 inhibitor) for treatment and prevention of recurrent attacks of hereditary angioedema in children